Welcome back to Money Movers. Take a look at Tylenol maker Ken View. Down over 7% at record lows now following reports that the Trump administration is planning to link Tylenol to autism risk during pregnancy.A Ken View spokesperson telling CNBC in part, quote, "We believe independent sound science clearly shows that taking acetamophen does not cause autism." President Trump is scheduled to make remarks on quote significant medical and scientific findings for America's children at 400 pm Eastern time today. ...

Group 1: Nvidia and OpenAI Investment - Nvidia announced a $100 billion investment in OpenAI to develop AI data centers, leading to a rise in its stock price and boosting major U.S. equity indexes [2][6] - Nvidia's investment positively impacted its partners, including Super Micro Computer and Micron Technology, which also saw their stock prices increase [2] Group 2: Semiconductor Equipment Sector - Teradyne's shares surged after Susquehanna raised its price target from $133 to $200, indicating expected growth in demand for semiconductor equipment [3] - Other semiconductor equipment manufacturers, such as Applied Materials, ASML, and Lam Research, also experienced stock price increases [3] Group 3: Apple and iPhone Demand - Apple shares rose as Wedbush increased its price target for the stock to $310 from $270, citing better-than-expected demand for the iPhone 17 [4][6] Group 4: Mergers and Acquisitions - Metsera's shares soared after Pfizer announced plans to acquire the biopharma firm for up to $7.3 billion, capitalizing on the rising demand for weight-loss medications [4] Group 5: Real Estate Sector - Anywhere Real Estate's shares increased following the announcement of its acquisition by rival Compass, while Compass's shares declined [5] Group 6: Other Notable Movements - Kenvue's shares fell after reports linking its Tylenol product to autism, while Coinbase Global's shares dropped as major cryptocurrency prices declined [5][6]

Rising corporate earnings expectations are a bullish backdrop for stocks. According to Bloomberg Intelligence, more than 22% of companies in the S&P 500 provided guidance for their Q3 earnings results that are expected to beat analysts’ expectations, the highest in a year. Also, S&P companies are expected to post +6.9% earnings growth in Q3, up from +6.7% as of the end of May.The price of Bitcoin (^BTCUSD) today is down by more than -2% at a 1.5-week low, driven by long liquidation pressures. According to d ...

Market Overview - U.S. equity markets opened lower on September 22, 2025, following a record-high closing last week, reflecting cautious sentiment ahead of key economic data and Federal Reserve commentary [1][2] - The S&P 500 dipped approximately 0.2%, while the Dow Jones Industrial Average fell by 169 to 228 points (0.37% to 0.5%), and the Nasdaq Composite eased back by 0.1% to 0.2% [2] Economic Indicators - The market's overall trajectory has been upward since hitting a bottom in April, driven by expectations of continued rate cuts from the Federal Reserve [3] - Investors are particularly focused on upcoming inflation data, including the Personal Consumption Expenditures (PCE) price index, which is expected to show a slight increase [5] Corporate Developments - Pfizer (PFE) announced its intent to acquire Metsera (MTSR) for $4.9 billion, leading to a 60% surge in Metsera's shares and a 1.5% increase in Pfizer's stock [6] - FedEx Corp. (FDX) shares advanced 2.3% after reporting strong first-quarter fiscal 2026 adjusted earnings [6] - Lennar Corp. (LEN) saw a 4.2% decline in shares after its third-quarter fiscal 2025 adjusted earnings fell short of estimates [6] - Newmont Corp. (NEM) shares surged 4.3% following the sale of its stake in Orla Mining [6] - Brighthouse Financial Inc. (BHF) shares jumped 27.2% amid acquisition talks with Aquarian Holdings [6] Technology Sector News - Oracle (ORCL) gained 4% following reports of discussions with Meta for a potential $20 billion cloud computing deal [10] - Oklo (OKLO) shares climbed 28% due to a substantial UK-US nuclear energy partnership valued at $350 billion [10] - Apple (AAPL) shares rose 3.2% after a J.P. Morgan upgrade and the global launch of its newest iPhone model [10] - Tesla (TSLA) added 2.2% following a positive upgrade from Baird [10]

Market Overview - US futures are weaker after all major indexes closed at all-time highs (ATHs) on Friday, with S&P and Nasdaq futures down 0.3% as of 8:10 am [1] - The S&P is notably overbought, but bullish analysts suggest the overall uptrend may continue due to rising earnings expectations and market bets on two more rate cuts this year [1] - Pre-market trading shows Mag 7 stocks under pressure, with only TSLA and AAPL in the green [3] Corporate News - MediaTek is launching a new mobile processor aimed at competing with Qualcomm in handling agentic AI tasks [4] - BYD shares dropped following an investigation into Amer Sports due to environmental concerns related to a fireworks show [4] - Anywhere Real Estate shares soared 46% on a merger agreement with Compass Inc., while Compass shares fell 12% [4] - Cryptocurrency-exposed stocks, including Coinbase, are declining after over $1.5 billion in bullish bets were liquidated [4] - ASML shares rose 3% after receiving a third analyst upgrade in a month, indicating potential cyclical recovery [4] - Ionis shares increased 2% after a successful study announcement for its drug in treating Alexander disease [4] - Kenvue shares fell 5% after reports linked its drug's active ingredient to autism, which Kenvue disputed [4] - MBX Biosciences shares climbed 30% following positive Phase 2 clinical trial results [4] - Metsera shares surged 59% after Pfizer agreed to acquire the obesity startup for approximately $4.9 billion [4] - T-Mobile US shares slipped 1% after announcing a leadership change [4] Economic Indicators - The Federal Reserve's recent rate cut has led to a thin data calendar this week, with the main focus on the preferred inflation gauge release on Friday [6] - The upcoming payrolls report is anticipated to be a significant catalyst alongside the start of the earnings season next month [6] - Market sentiment is expected to drift this week due to the calm macro environment and the end of the earnings season [7] Precious Metals and Commodities - Gold prices hit a record high above $3,700, with ETF inflows reaching a three-year high, driven by expectations of further Fed rate cuts [12][19] - Silver prices also rose, reaching their highest level since 2011 [12] - Crude oil prices remained flat, while agricultural commodities mostly weakened [1][4] Global Market Movements - European stocks opened lower, with automobile and banking shares leading declines, while mining and technology stocks outperformed [14] - Asian stocks rose, supported by regional tech shares and a rally in Japan, with Samsung Electronics shares surging after passing Nvidia's quality test [15] - The MSCI Asia Pacific Index increased by 0.2%, led by gains in TSMC [15]

Group 1 - Kenvue Inc. (NYSE:KVUE) is perceived to have litigation risks that are not as severe as commonly believed, with current stock performance at 4.5% and new leadership in place [1] - Kenvue is a consumer health company with notable brands such as Tylenol, Listerine, and Neutrogena, and has opportunities to unlock value through reinvestment in underfunded brands and cost structure optimization [1] - The stock has underperformed due to operational challenges, a new 145% import tariff affecting margins, and lower-than-expected product demand, but is considered inexpensive relative to its brand portfolio quality [1] Group 2 - Despite the potential of Kenvue as an investment, certain AI stocks are viewed as having greater upside potential and lower downside risk [1]

Group 1 - Kenvue Inc. (NYSE:KVUE) is recognized as one of the 10 Best NYSE Dividend Stocks to Buy, highlighting its strong position in the market [1] - The company produces and sells a variety of consumer health products, including over-the-counter medicines, personal care, and wellness items, featuring well-known brands like Tylenol, Neutrogena, and Listerine [2] - Following its separation from Johnson & Johnson in 2023, Kenvue has focused on enhancing brand relevance through digital tools and consumer insights, while also modernizing its supply chain and ensuring regulatory compliance [3] Group 2 - Kenvue has been designated as a Dividend King, offering a quarterly dividend of $0.2075 per share, which was increased by 1.2% in July, resulting in a dividend yield of 4.53% as of September 20 [4]

Company Overview - Kenvue Inc. is a consumer health company offering well-known brands in pain management, skin and beauty, oral care, and cough, cold, and allergy care, including Tylenol, Listerine, and Neutrogena [1] Earnings Report - Kenvue is set to report its Q3 2025 earnings on November 6, with Wall Street analysts expecting an EPS of $0.27, a decrease from $0.28 in the prior-year period [2] - Quarterly revenue is anticipated to be $3.86 billion, down from $3.90 billion a year earlier [2] - The company reported Q2 2025 earnings on August 7, posting adjusted EPS of $0.29, which beat the consensus estimate of $0.28, while revenues of $3.84 billion fell short of the consensus of $3.94 billion [3] Financial Outlook - The CFO stated that the outlook for 2025 is being adjusted to reflect year-to-date results and expectations for the second half of the year, considering the dynamic external environment [4] - For the full year 2025, Kenvue expects net sales and organic sales to decline by low single digits [4] Dividend Information - Kenvue's dividend yield is currently 4.58%, with a total of $0.83 per share paid in dividends over the last 12 months [2] - To earn $100 per month from Kenvue dividends, an investment of approximately $26,201 is required, which equates to around 1,420 shares at a price of $18.45 each [5][6]

Company Insights - Western Union announced the acquisition of Intermex for approximately $500 million, aimed at strengthening its position in the high-growth Latin American markets [1] - Johnson Controls raised its dividend from 37 cents to 40 cents per share on September 10 [2] - MNTN reported a second-quarter loss of 65 cents per share, an improvement from a loss of 69 cents per share a year ago, with quarterly sales of $68.460 million, exceeding analyst estimates of $64.483 million [2] - Nordic American Tankers posted weaker-than-expected quarterly sales on August 28, leading to a negative outlook from analysts [3] - Occidental Petroleum maintained a Neutral rating from UBS, with a price target increase from $45 to $46 [3][4] - Kenvue received a Neutral rating from Citigroup, with a price target reduction from $22 to $20 [4] Stock Performance - Western Union shares fell 1.7% to settle at $8.20 [7] - Johnson Controls shares gained 1% to close at $108.48 [7] - MNTN shares rose 0.1% to settle at $20.08 [7] - Nordic American shares fell 0.3% to $3.30 [7] - Occidental Petroleum shares rose 0.4% to close at $47.36 [7] - Kenvue shares fell 1.3% to settle at $18.10 [7]

Core Concept - The concept of a wide moat refers to companies with strong, lasting competitive advantages that protect them from competition and enable long-term profitability [1] Group 1: Companies with Wide Moats - Recognized companies with wide moats include Microsoft Corporation, Johnson & Johnson, S&P Global Inc., and NIKE, Inc., all operating in industries with significant barriers to entry [2] - Companies with wide economic moats benefit from brand strength, cost advantages, network effects, regulatory barriers, and economies of scale, making it difficult for competitors to erode their market share [3] Group 2: Investment Rationale - Investing in wide-moat businesses is seen as a strategy for steady, long-term returns, as these companies tend to be more resilient during economic downturns compared to those in highly competitive industries [4] - Wide-moat companies typically produce steady cash flows, navigate market volatility effectively, and deliver value to shareholders through dividends and stock price growth [5] Group 3: Microsoft Corporation - Microsoft holds a dominant position due to its ecosystem of software, cloud services, and enterprise solutions, creating high switching costs for customers [7] - In fiscal 2025, Microsoft's AI business surpassed a $13 billion annual revenue run rate, growing 175% year over year, while cloud revenues exceeded $168 billion with 23% growth [8] - Microsoft achieved unprecedented scale with commercial bookings exceeding $100 billion for the first time, demonstrating strong enterprise penetration and significant expansion in large contracts [9] - The company generated outstanding cash flow in fiscal 2025, showcasing its financial strength and ability to invest in AI infrastructure [10] - Microsoft is uniquely positioned to capitalize on the multi-trillion-dollar AI opportunity while maintaining financial stability and robust shareholder returns [11] Group 4: Johnson & Johnson - Johnson & Johnson enjoys a wide moat in healthcare due to its diversified portfolio, trusted brand, and extensive R&D capabilities, with regulatory barriers further protecting its position [12] - The company has over 275 subsidiaries, indicating strong diversification that helps it withstand economic cycles [13] - JNJ expects to generate more than $57 billion in sales in its Innovative Medicines segment in 2025, with anticipated growth of 5-7% from 2025 to 2030 [15] Group 5: S&P Global - S&P Global benefits from an economic moat driven by brand strength, regulatory influence, and data-driven services, with its credit rating business being essential for various market participants [16] - The company's proprietary financial data and analytics services provide indispensable tools, ensuring customer reliance and giving it pricing power [17] - The growing demand for business information services and risk mitigation is expected to drive market growth for S&P Global [18][19] Group 6: NIKE, Inc. - NIKE is the global leader in athletic footwear and apparel, with unmatched scale and cultural dominance, despite facing revenue challenges in fiscal 2025 [20] - The company maintains strong brand equity through powerful athlete partnerships and cultural relevance, positioning it for sustainable expansion [21] - NIKE is executing its "Win Now" strategy to restore brand momentum and streamline its portfolio, focusing on performance-led categories and women's sportswear [22] - The company is enhancing its integrated marketplace by strengthening NIKE Direct and expanding through strategic partnerships with Amazon and Urban Outfitters [23]